Advertisement

Topics

Anti-PD-1 treatment reduces tumor size and post-surgical relapse of lung cancer

09:54 EDT 16 Apr 2018 | News-Medical.net

A drug given to early stage lung cancer patients before they undergo surgery showed major tumor responses in the removed tumor and an increase in anti-tumor T-cells that remained after the tumor was removed, which resulted in fewer relapse cases in the patients.

Original Article: Anti-PD-1 treatment reduces tumor size and post-surgical relapse of lung cancer

NEXT ARTICLE

More From BioPortfolio on "Anti-PD-1 treatment reduces tumor size and post-surgical relapse of lung cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...